Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Positive predictive values of hematological procedure codes in the Danish National Patient Registry - a population-based validation study

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes

    Research output: Contribution to journalJournal articlepeer-review

  2. Can we identify allergic rhinitis from administrative data: A validation study

    Research output: Contribution to journalJournal articlepeer-review

  3. The impact of socioeconomic status on the risk of total hip arthroplasty during 1995 to 2017 in Denmark

    Research output: Contribution to journalConference abstract in journalpeer-review

  4. All-cause mortality, suicide and self-harm in patients with treatment-resistant depression

    Research output: Contribution to journalJournal articlepeer-review

  5. GWAS of antidepressant treatment non-response in depression

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

BACKGROUND: The Danish National Patient Registry holds data on hematological procedure codes including date and type of treatment from all hematological departments in Denmark. The validity of the hematological procedure codes remains to be clarified before they are used in epidemiological research.

PATIENTS AND METHODS: Using the Danish Myelodysplastic Syndromes Database, we identified 897 patients diagnosed with myelodysplastic syndromes or chronic myelomonocytic leukemia treated at five Danish Hospitals between 1 January 2012 and 30 April 2019. From the Danish National Patient Registry, we ascertained information about hematological procedure codes and date of procedure registered on each patient and generated random samples. Using medical record review as the reference standard, we validated procedure codes in the Danish National Patient Registry and calculated positive predictive values (PPVs) with 95% confidence intervals (CIs) for each procedure code.

RESULTS: A total of 523 medical records (99% of the total sample) were available for review. PPVs for specific procedure codes ranged from 71% to 100%. The overall PPV was 91% (95% CI: 88%-92%), reflecting PPVs of 95% (95% CI: 92%-97%) for low-dose-chemotherapy, 90% (95% CI: 81%-96%) for high-dose chemotherapy, 99% (95% CI: 93%-100%) for allogeneic stem cell transplantation, 75% (95% CI: 62%-85%) for immuno-modulating agents, 80% (95% CI: 74%-85%) for growth factors, and 99% (95% CI: 99%-100%) for bone marrow examination. The accuracy of coding was consistent across geographic regions and year of registration/coding.

CONCLUSIONS: Hematological procedure codes reported to the Danish National Patient Registry had high PPVs and are suitable for epidemiological research.

Original languageEnglish
JournalPharmacoepidemiology and Drug Safety
ISSN1053-8569
DOIs
Publication statusE-pub ahead of print - 31 May 2022

Bibliographical note

This article is protected by copyright. All rights reserved.

ID: 78360951